Efficacy of denosumab versus alendronate for aromatase inhibitor-associated osteoporosis in postmenopausal breast cancer patients: a retrospective analysis.
Saved in:
| Title: | Efficacy of denosumab versus alendronate for aromatase inhibitor-associated osteoporosis in postmenopausal breast cancer patients: a retrospective analysis. |
|---|---|
| Authors: | Zhang Y; The Eighth Clinical Medical College of Guangzhou, University of Chinese Medicine, Foshan, 528000, Guangdong, China., Cui W; The Eighth Clinical Medical College of Guangzhou, University of Chinese Medicine, Foshan, 528000, Guangdong, China., Hou L; The Eighth Clinical Medical College of Guangzhou, University of Chinese Medicine, Foshan, 528000, Guangdong, China. 704270245@qq.com.; Foshan Hospital of Traditional Chinese Medicine, Foshan, 528000, Guangdong, China. 704270245@qq.com. |
| Source: | BMC musculoskeletal disorders [BMC Musculoskelet Disord] 2025 Nov 12; Vol. 26 (1), pp. 1040. Date of Electronic Publication: 2025 Nov 12. |
| Publication Type: | Journal Article; Comparative Study |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100968565 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2474 (Electronic) Linking ISSN: 14712474 NLM ISO Abbreviation: BMC Musculoskelet Disord Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1471-2474 |
|---|---|
| DOI: | 10.1186/s12891-025-09280-w |
